Oxford Nanopore Technologies PLC (ONT)

Industry Biotechnology


This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

114.80p

Buy

115.00p

arrow-up1.50p (+1.32%)

Prices updated at 03 Aug 2026, 16:49 BST
| Prices minimum 15 mins delay
|
Prices in GBX

Sector
Healthcare
Industry
Biotechnology
Chairman
Mr. Duncan Eden Tatton-Brown
CEO
Mr. Francis Van Parys
Most recent earnings
31 Dec 2025
Fiscal year end
31 Dec 2025
Employees
1,335
Head office
Edmund Halley Road
Oxford
United Kingdom
OX4 4DQ
mobile
+44 8450347900
letter
-

Key personnel

Salary
Ms. Katherine Sophie Priestman
Non-Executive Director, Senior Independent Director
-
Mr. Duncan Eden Tatton-Brown
Non-Executive Director, Chairman
-
Mr. Adrian Nevil Hennah
Non-Executive Director
-
Mr. John O'Higgins
Non-Executive Director
-
Mr. Nicholas Patrick Keher
Executive Director, Chief Financial Officer
-
Mr. Francis Van Parys
Executive Director, Chief Executive Officer
-

Top 5 shareholders

No. of shares
Baillie Gifford & Co Limited.19,969,731
M&G Investment Management Limited18,875,498
Edinburgh Worldwide12,667,767
Vanguard10,805,540
M&G UK Sustain Paris Aligned Fund9,407,599

Director dealings

Action
14 Jul 2026Purchase
14 Jul 2026Transfer in
14 Jul 2026Transfer in
14 Jul 2026Purchase
12 Jun 2026Transfer in
12 Jun 2026Purchase
12 Jun 2026Purchase
12 Jun 2026Transfer in
13 May 2026Purchase
13 May 2026Transfer in
13 May 2026Purchase
13 May 2026Transfer in
11 May 2026Purchase
14 Apr 2026Exercise of Option
14 Apr 2026Purchase
14 Apr 2026Transfer in
14 Apr 2026Sale
14 Apr 2026Transfer in
14 Apr 2026Purchase
02 Apr 2026Purchase
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser.

© Copyright 2026 Morningstar. All rights reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

The ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.